Stephen L Schmidt1, Jennifer J Peters2, Dennis A Turner3, Warren M Grill4. 1. Biomedical Engineering Department, Duke University, Durham, NC, USA. Electronic address: stephen.schmidt@duke.edu. 2. Biomedical Engineering Department, Duke University, Durham, NC, USA. 3. Biomedical Engineering Department, Duke University, Durham, NC, USA; Neurobiology and Neurosurgery Departments, Duke University Medical Center, Durham, NC, USA. 4. Biomedical Engineering Department, Duke University, Durham, NC, USA; Neurobiology and Neurosurgery Departments, Duke University Medical Center, Durham, NC, USA; Electrical and Computer Engineering Department, Duke University, Durham, NC, USA. Electronic address: warren.grill@duke.edu.
Abstract
BACKGROUND: Neural oscillations represent synchronous neuronal activation and are ubiquitous throughout the brain. Oscillatory activity often includes brief high-amplitude bursts in addition to background oscillations, and burst activity may predict performance on working memory, motor, and comprehension tasks. OBJECTIVE: We evaluated beta burst activity as a possible biomarker for motor symptoms in Parkinson's disease (PD). The relationship between beta amplitude dynamics and motor symptoms is critical for adaptive DBS for treatment of PD. METHODS: We applied threshold-based and support vector machine (SVM) analyses of burst parameters to a defined on/off oscillator and to intraoperative recordings of local field potentials from the subthalamic nucleus of 16 awake patients with PD. RESULTS: Filtering and time-frequency analysis techniques critically influenced the accuracy of identifying burst activity. Threshold-based analysis lead to biased results in the presence of changes in long-term beta amplitude and accurate quantification of bursts with thresholds required unknowable a priori knowledge of the time in bursts. We therefore implemented an SVM analysis, and we did not observe changes in burst fraction, rate, or duration with the application of cDBS in the participant data, even though SVM analysis was able to correctly identify bursts of the defined on/off oscillator. CONCLUSION: Our results suggest that cDBS of the STN may not change beta burst activity. Additionally, threshold-based analysis can bias the fraction of time spent in bursts. Improved analysis strategies for continuous and adaptive DBS may achieve improved symptom control and reduce side-effects.
BACKGROUND: Neural oscillations represent synchronous neuronal activation and are ubiquitous throughout the brain. Oscillatory activity often includes brief high-amplitude bursts in addition to background oscillations, and burst activity may predict performance on working memory, motor, and comprehension tasks. OBJECTIVE: We evaluated beta burst activity as a possible biomarker for motor symptoms in Parkinson's disease (PD). The relationship between beta amplitude dynamics and motor symptoms is critical for adaptive DBS for treatment of PD. METHODS: We applied threshold-based and support vector machine (SVM) analyses of burst parameters to a defined on/off oscillator and to intraoperative recordings of local field potentials from the subthalamic nucleus of 16 awake patients with PD. RESULTS: Filtering and time-frequency analysis techniques critically influenced the accuracy of identifying burst activity. Threshold-based analysis lead to biased results in the presence of changes in long-term beta amplitude and accurate quantification of bursts with thresholds required unknowable a priori knowledge of the time in bursts. We therefore implemented an SVM analysis, and we did not observe changes in burst fraction, rate, or duration with the application of cDBS in the participant data, even though SVM analysis was able to correctly identify bursts of the defined on/off oscillator. CONCLUSION: Our results suggest that cDBS of the STN may not change beta burst activity. Additionally, threshold-based analysis can bias the fraction of time spent in bursts. Improved analysis strategies for continuous and adaptive DBS may achieve improved symptom control and reduce side-effects.
Authors: Doris D Wang; Coralie de Hemptinne; Svjetlana Miocinovic; Jill L Ostrem; Nicholas B Galifianakis; Marta San Luciano; Philip A Starr Journal: J Neurosci Date: 2018-04-16 Impact factor: 6.167
Authors: A Priori; G Foffani; A Pesenti; F Tamma; A M Bianchi; M Pellegrini; M Locatelli; K A Moxon; R M Villani Journal: Exp Neurol Date: 2004-10 Impact factor: 5.330
Authors: Flavie Torrecillos; Gerd Tinkhauser; Petra Fischer; Alexander L Green; Tipu Z Aziz; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Keyoumars Ashkan; Peter Brown; Huiling Tan Journal: J Neurosci Date: 2018-09-04 Impact factor: 6.167
Authors: Diane Whitmer; Camille de Solages; Bruce Hill; Hong Yu; Jaimie M Henderson; Helen Bronte-Stewart Journal: Front Hum Neurosci Date: 2012-06-04 Impact factor: 3.169
Authors: Simon Little; Martijn Beudel; Ludvic Zrinzo; Thomas Foltynie; Patricia Limousin; Marwan Hariz; Spencer Neal; Binith Cheeran; Hayriye Cagnan; James Gratwicke; Tipu Z Aziz; Alex Pogosyan; Peter Brown Journal: J Neurol Neurosurg Psychiatry Date: 2015-09-30 Impact factor: 10.154
Authors: Ying Yu; David Escobar Sanabria; Jing Wang; Claudia M Hendrix; Jianyu Zhang; Shane D Nebeck; Alexia M Amundson; Zachary B Busby; Devyn L Bauer; Matthew D Johnson; Luke A Johnson; Jerrold L Vitek Journal: J Neurosci Date: 2021-01-22 Impact factor: 6.167
Authors: R W Anderson; Y M Kehnemouyi; R S Neuville; K B Wilkins; C M Anidi; M N Petrucci; J E Parker; A Velisar; H M Brontë-Stewart Journal: J Neurosci Methods Date: 2020-06-18 Impact factor: 2.390
Authors: Stephen L Schmidt; David T Brocker; Brandon D Swan; Dennis A Turner; Warren M Grill Journal: Brain Stimul Date: 2020-10-06 Impact factor: 8.955
Authors: Timothy O West; Peter J Magill; Andrew Sharott; Vladimir Litvak; Simon F Farmer; Hayriye Cagnan Journal: PLoS Comput Biol Date: 2022-03-04 Impact factor: 4.475
Authors: AnneMarie K Brinda; Alex M Doyle; Madeline Blumenfeld; Jordan Krieg; Joseph S R Alisch; Chelsea Spencer; Emily Lecy; Lucius K Wilmerding; Adele DeNicola; Luke A Johnson; Jerrold L Vitek; Matthew D Johnson Journal: J Neural Eng Date: 2021-05-13 Impact factor: 5.379
Authors: Elena Brazhnik; Nikolay Novikov; Alex J McCoy; Neda M Ilieva; Marian W Ghraib; Judith R Walters Journal: Neurobiol Dis Date: 2021-05-15 Impact factor: 5.996
Authors: Tommaso Bocci; Marco Prenassi; Mattia Arlotti; Filippo Maria Cogiamanian; Linda Borellini; Elena Moro; Andres M Lozano; Jens Volkmann; Sergio Barbieri; Alberto Priori; Sara Marceglia Journal: NPJ Parkinsons Dis Date: 2021-09-28